Achievement of Target Systolic Blood Pressure for Lowering the Risk of Major Adverse Cardiovascular Events: From the Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial

被引:0
|
作者
Hartaigh, Briain O.
Szymonifka, Jackie
Okin, Peter M.
机构
关键词
Diabetes Mellitus; Blood pressure; Antihypertensive agents; Cardiovascular disease prevention; Epidemiology;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
13850
引用
收藏
页数:3
相关论文
共 50 条
  • [21] What is the impact of systolic blood pressure lowering on preventing cardiovascular events?
    N M Kaplan
    [J]. Journal of Human Hypertension, 2004, 18 : S1 - S1
  • [22] What is the impact of systolic blood pressure lowering on preventing cardiovascular events?
    Kaplan, NM
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (Suppl 2) : S1 - S1
  • [23] Age, Cardiovascular Risk, and Blood Pressure Target
    Messerli, Franz H.
    Grodzicki, Tomasz
    Messerli, Adrian
    Bangalore, Sripal
    Rexhaj, Emrush
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (07) : 818 - 819
  • [24] Refining determinants of associations of visit-to-visit blood pressure variability with cardiovascular risk: results from the Action to Control Cardiovascular Risk in Diabetes Trial
    Nuyujukian, Daniel S.
    Zhou, Jin J.
    Koska, Juraj
    Reaven, Peter D.
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 (11) : 2173 - 2182
  • [25] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Dae Hyun Kim
    Curtis Tatsuoka
    Zhengyi Chen
    Jackson T. Wright
    Michelle C. Odden
    Srinivasan Beddhu
    Brandon K. Bellows
    Adam Bress
    Thaddeus Carson
    William C. Cushman
    Karen C. Johnson
    Donald E. Morisky
    Henry Punzi
    Leonardo Tamariz
    Song Yang
    Lee-Jen Wei
    [J]. Journal of General Internal Medicine, 2022, 37 : 3797 - 3804
  • [26] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Kim, Dae Hyun
    Tatsuoka, Curtis
    Chen, Zhengyi
    Wright, Jackson T.
    Odden, Michelle C.
    Beddhu, Srinivasan
    Bellows, Brandon K.
    Bress, Adam
    Carson, Thaddeus
    Cushman, William C.
    Johnson, Karen C.
    Morisky, Donald E.
    Punzi, Henry
    Tamariz, Leonardo
    Yang, Song
    Wei, Lee-Jen
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (15) : 3797 - 3804
  • [27] Pulse Pressure, Cardiovascular Events, and Intensive mood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Pareek, Manan
    Vaduganathan, Muthiah
    Biering-Sorensen, Tor
    Byrne, Christina
    Qamar, Arman
    Almarzooq, Zaid
    Pandey, Ambarish
    Olsen, Michael Hecht
    Bhatt, Deepak L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06): : 733 - 739
  • [28] Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial
    Pareek, M.
    Byrne, C.
    Mikkelsen, A. D.
    Kristensen, A. M. Dyrvig
    Vaduganathan, M.
    Biering-Sorensen, T.
    Kragholm, K. H.
    Mortensen, M. B.
    Singh, A.
    Olsen, M. H.
    Bhatt, D. L.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 2312 - 2312
  • [29] Systolic Blood Pressure and Cardiovascular Risk: Straightening the Evidence
    Mccarthy, Cian P.
    Natarajan, Pradeep
    [J]. HYPERTENSION, 2023, 80 (03) : 577 - 579
  • [30] Systolic blood pressure: an underestimated cardiovascular risk factor
    Mancia, G
    Seravalle, G
    Grassi, G
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 : S21 - S27